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Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. 
Unresectable HCC is currently being treated with local injections of chemotherapeutics or radioactive 
particles during transarterial liver catheterization. The latter aims to increase local drug 
concentrations in the region of tumor(s), while limiting systemic toxicity. Although this technique is 
promising, the optimal treatment conditions (such as the injection location and dose) are still 
unknown. Given that the hepatic vasculature feeding the tumor plays a key role in the drug 
transport, this study explored the added value of computational models to optimize targeted drug 
delivery for HCC. 
A 3D hepatic arterial geometry was obtained based on micro-CT data of a human liver, and meshed 
resulting in 8.9 million volume elements. Computational fluid dynamics calculations simulated the 
blood flow (continuous shear-thinning fluid phase) as well as the drug transport (discrete phase) in 
the liver. Boundary conditions included a velocity inlet of 0.155 m/s at the hepatic artery, an outlet 
flow distribution (Murray’s law) and a uniform surface injection of 104 particles. The impact of 
relevant parameters on the particle distribution was analyzed using a sensitivity study. 
Results showed that the particle distribution depends largely on the cross-sectional injection 
location: a good choice of this parameter may allow targeting specific outlets or tumors. Other 
parameters with a significant impact on the particle distribution are the injection plane 
(proximal/distal catheter position), the particle density (1600-3600 kg/m³), and the particle diameter 
(40-100 µm), leading to changes in the outlet-specific number of exiting particles up to ± 64%, 61%, 
and 79%, respectively.  
 
This feasibility study indicates the potential of patient-specific computational models to optimize 
targeted drug delivery for liver cancer. Future work will focus on validating and testing the model 
retrospectively in a patient cohort that underwent transarterial therapy. 
 
